๐Œ๐ข๐ญ๐ฌ๐ฎ๐ข ๐‚๐ก๐ž๐ฆ๐ข๐œ๐š๐ฅ๐ฌ ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฌ ๐ข๐ง ๐Œ๐š๐ญ๐ž๐ซ๐ข๐š ๐๐ข๐จ๐ฐ๐จ๐ซ๐ค๐ฌ

 Mitsui Chemicals, Inc. announced today that it has made a minority investment in Materia Bioworks Inc. through 321Catalyst™, its corporate venture capital (CVC) fund.


#MateriaBioworks is a startup utilizing computational chemistry and AI to develop a platform (“MAPS”) that can efficiently design and formulate sustainable materials, such as #bioplastics. By leveraging computational chemistry and AI, the company streamlines product development using bioplastics, a process that traditionally required significant time and cost, thereby reducing development time and costs while also driving down the cost of bioplastics themselves.


Purpose of the Investment

By utilizing their biomass materials in Materia Bioworks’ bioplastic design services, #MitsuiChemicals aims to expand its provision of bioplastic materials offering to customers globally. Furthermore, Mitsui Chemicals will collaborate with Materia Bioworks to meet the performance and quality requirements of customers through the possible joint development of new bioplastic materials.


source : Mitsui Chemicals

Comments

Popular posts from this blog

Today's KNOWLEDGE Share : Robotic 3D printing can compete with traditional boatbuilding

Today's KNOWLEDGE Share : A BUG IN INJECTION MOLDING

Lummus Technology announced Vioneo has selected its Novolen®